Standard FDA review timelines of 1012 months (or roughly 6 months under priority review) make 2026 approval nearly impossible given the remaining calendar
In overweight or obese patients with NAFLD, a reduction in body weight 710% improves liver enzymes and the histological grade of the disease [66,67]
Such an effect results from different mechanisms, including the activation of muscarinic cholinergic receptors, and the increased expression of mGlu2 receptors in dorsal root ganglia neurons, by means of an acetylation mechanism involving transcription factors of the nuclear factor (NF)-kappaB family
Voice hoarseness is common after thyroid surgery and often goes away with time
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
An observational study evaluated the risk of type 2 diabetes associated with four genetic variants that may increase circulating phylloquinone (vitamin K1) concentrations